Dr. Nikunj Jain
Co-Founder and HOD - Nuclear Medicine ,MBBS, DRM, DNB, FEBNM, FANMB, Dip. CBNC
Lung cancer develops when abnormal cells in one or both lungs grow uncontrollably and form tumors. It often starts in the lining of the bronchi or lung tissues and may go unnoticed in its early stages due to subtle or absent symptoms. The lungs play a crucial role in supplying oxygen to the bloodstream and removing carbon dioxide from the body. Because lung cancer often doesn't produce symptoms early on, it's frequently diagnosed at an advanced stage. Diagnostic evaluation of lung cancer includes a variety of tools such as chest X-ray, CT scan, MRI, PET-CT, bronchoscopy, and biopsy. PET CT is especially effective in diagnosing lung cancer as it combines metabolic and anatomical imaging, allowing for early detection, staging, and treatment planning.
Lung cancer refers to the abnormal and uncontrolled growth of cells in the lungs that leads to tumor formation. It is broadly categorized into non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). NSCLC is more common, while SCLC is more aggressive and fast-spreading. Lung cancer is one of the leading causes of cancer-related deaths worldwide. While smoking is the primary risk factor, lung cancer can also occur in non-smokers due to other environmental or genetic factors. Early detection plays a crucial role in improving outcomes, and PET CT is a vital imaging modality for staging and guiding treatment strategies.
Lung cancer is mainly classified based on the appearance of cancer cells under the microscope:
Lung cancer symptoms may not appear until the disease has progressed. Common symptoms include:
While the exact cause of lung cancer may vary, known risk factors include:
PET CT (Positron Emission Tomography – Computed Tomography) is a powerful tool in the detection and management of lung cancer. It helps in:
PET CT combines functional imaging with anatomical imaging, offering detailed information on both metabolic activity and tumor location, which makes it indispensable in the management of lung cancer.
In addition to PET CT, a range of other tests are used to detect and assess lung cancer, including:
Lung cancer is a serious condition that arises from the uncontrolled growth of abnormal cells in the lungs, potentially spreading to other parts of the body. It is often asymptomatic in the early stages and is frequently diagnosed only when it becomes advanced. Risk factors include smoking, exposure to harmful substances, family history, and environmental pollutants. Common symptoms include persistent cough, breathlessness, and chest pain. Accurate and early detection of lung cancer significantly improves treatment success. Diagnostic options include imaging techniques, laboratory tests, and biopsy procedures. Among these, the PET CT scan stands out due to its ability to detect functional and structural changes in the lungs at the cellular level. This makes PET CT an essential tool for staging, treatment monitoring, and recurrence detection in lung cancer.
Book tests, view reports, and manage your health records on the go. Experience convenient healthcare with Molecular Diagnostics and Therapy.